期刊
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
卷 44, 期 2, 页码 320-339出版社
WILEY
DOI: 10.1111/acer.14253
关键词
Allopregnanolone; Neuroactive Steroid; GABA Inhibition; Corticotropin-Releasing Factor Signaling; Neuroimmune Signaling
资金
- UNC Bowles Center for Alcohol Studies [NIAAA-R01-AA024095]
For many years, research from around the world has suggested that the neuroactive steroid (3 alpha,5 alpha)-3-hydroxypregnan-20-one (allopregnanolone or 3 alpha,5 alpha-THP) may have therapeutic potential for treatment of various symptoms of alcohol use disorders (AUDs). In this critical review, we systematically address all the evidence that supports such a suggestion, delineate the etiologies of AUDs that are addressed by treatment with allopregnanolone or its precursor pregnenolone, and the rationale for treatment of various components of the disease based on basic science and clinical evidence. This review presents a theoretical framework for understanding how endogenous steroids that regulate the effects of stress, alcohol, and the innate immune system could play a key role in both the prevention and the treatment of AUDs. We further discuss cautions and limitations of allopregnanolone or pregnenolone therapy with suggestions regarding the management of risk and the potential for helping millions who suffer from AUDs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据